S&P affirms Medpace

Standard & Poor's said it affirmed its B+ corporate credit rating on Medpace Inc. The outlook is stable.

The agency said it also affirmed its B+ rating on the company's term loan and revolving credit facility. The recovery rating on this debt is 4.

The agency said the rating on Medpace Inc. reflects the company's weak business risk profile, highlighted by its position as a small niche player in contract research services and uncertain demand in the contract-based business.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.